N,5-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine;N,6-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine

C46H56N12O8S2 — CID 161392112

IUPACN,5-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine;N,6-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine
SMILESCNc1nc2cc(C)ccc2n1-c1nc2c(c(C3(S(C)(=O)=O)CCC3)n1)OC[C@@H]1COCCN21.CNc1nc2ccc(C)cc2n1-c1nc2c(c(C3(S(C)(=O)=O)CCC3)n1)OC[C@@H]1COCCN21
InChIInChI=1S/2C23H28N6O4S/c1-14-5-6-17-16(11-14)25-21(24-2)29(17)22-26-19(23(7-4-8-23)34(3,30)31)18-20(27-22)28-9-10-32-12-15(28)13-33-18;1-14-5-6-16-17(11-14)29(21(24-2)25-16)22-26-19(23(7-4-8-23)34(3,30)31)18-20(27-22)28-9-10-32-12-15(28)13-33-18/h2*5-6,11,15H,4,7-10,12-13H2,1-3H3,(H,24,25)/t2*15-/m00/s1
InChIKeyVTCTVVREOSOOHQ-HJIBXMCBSA-N
MW969.16 g/mol
LogP4.37
Rot. Bonds8

About N,5-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine;N,6-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine

N,5-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine;N,6-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine (PubChem CID 161392112) has the molecular formula C46H56N12O8S2 and a molecular weight of 969.16 g/mol. Its IUPAC name is N,5-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine;N,6-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine.

Molecular Properties

Compound NameN,5-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine;N,6-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine
PubChem CID161392112
Molecular FormulaC46H56N12O8S2
Molecular Weight969.16 g/mol
Exact Mass968.38
IUPAC NameN,5-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine;N,6-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine
SMILESCNc1nc2cc(C)ccc2n1-c1nc2c(c(C3(S(C)(=O)=O)CCC3)n1)OC[C@@H]1COCCN21.CNc1nc2ccc(C)cc2n1-c1nc2c(c(C3(S(C)(=O)=O)CCC3)n1)OC[C@@H]1COCCN21
InChIInChI=1S/2C23H28N6O4S/c1-14-5-6-17-16(11-14)25-21(24-2)29(17)22-26-19(23(7-4-8-23)34(3,30)31)18-20(27-22)28-9-10-32-12-15(28)13-33-18;1-14-5-6-16-17(11-14)29(21(24-2)25-16)22-26-19(23(7-4-8-23)34(3,30)31)18-20(27-22)28-9-10-32-12-15(28)13-33-18/h2*5-6,11,15H,4,7-10,12-13H2,1-3H3,(H,24,25)/t2*15-/m00/s1
InChIKeyVTCTVVREOSOOHQ-HJIBXMCBSA-N
XLogP4.37
TPSA222.94 Ų
H-Bond Donors2
H-Bond Acceptors20
Rotatable Bonds8
Heavy Atoms68
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500969.16
LogP ≤ 54.37
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1020

Analyze N,5-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine;N,6-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N,5-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine;N,6-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine?
The IUPAC name of N,5-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine;N,6-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine (CID 161392112) is N,5-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine;N,6-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine.
What is the SMILES notation for N,5-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine;N,6-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine?
The canonical SMILES for N,5-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine;N,6-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine is CNc1nc2cc(C)ccc2n1-c1nc2c(c(C3(S(C)(=O)=O)CCC3)n1)OC[C@@H]1COCCN21.CNc1nc2ccc(C)cc2n1-c1nc2c(c(C3(S(C)(=O)=O)CCC3)n1)OC[C@@H]1COCCN21.
What is the InChIKey of N,5-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine;N,6-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine?
The InChIKey is VTCTVVREOSOOHQ-HJIBXMCBSA-N. The full InChI is InChI=1S/2C23H28N6O4S/c1-14-5-6-17-16(11-14)25-21(24-2)29(17)22-26-19(23(7-4-8-23)34(3,30)31)18-20(27-22)28-9-10-32-12-15(28)13-33-18;1-14-5-6-16-17(11-14)29(21(24-2)25-16)22-26-19(23(7-4-8-23)34(3,30)31)18-20(27-22)28-9-10-32-12-15(28)13-33-18/h2*5-6,11,15H,4,7-10,12-13H2,1-3H3,(H,24,25)/t2*15-/m00/s1.
What are the key properties of N,5-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine;N,6-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine?
N,5-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine;N,6-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine has a molecular weight of 969.16 g/mol, XLogP of 4.37, 8 rotatable bonds, 2 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N,5-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine;N,6-dimethyl-1-[(10S)-6-(1-methylsulfonylcyclobutyl)-8,12-dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]benzimidazol-2-amine is sourced from PubChem (CID 161392112), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).